Olodaterol (brand name: Striverdi®) is a bronchodilator belonging to the group of beta-2-symptomimetics. It is used for the symptomatic long-term treatment of COPD, a chronic obstructive pulmonary disease in which the airways are permanently narrowed. It thus helps sufferers to breathe more easily.
It can be used alone or (since 2016) in combination with tiotropium, an anticholinergic.
Use & Indications
Olodaterol is inhaled both alone as a solution and in combination with other active ingredients, always using the Respiramat inhalation device.
This works purely mechanically and does not require any electrical energy, for example from a battery. During use, it generates a spray cloud consisting of very fine droplets that spreads very slowly. In contrast to conventional inhalation devices, this enables a more coordinated intake. Thus, less active ingredient remains in the mouth/throat and most of it reaches the lungs directly for a more targeted intake.
One dose comprises two sprays (2.5 µg/stroke), i.e. it must be sprayed and inhaled twice in succession. This application takes place once a day, always at the same time of day, since the duration of action of olodaterol is 24 hours.
This information applies to both Striverdi® and Spiolto®.